GB0621822D0 - Predictor of nocturnal hypoglyceamia for individuals with diabetes - Google Patents

Predictor of nocturnal hypoglyceamia for individuals with diabetes

Info

Publication number
GB0621822D0
GB0621822D0 GBGB0621822.6A GB0621822A GB0621822D0 GB 0621822 D0 GB0621822 D0 GB 0621822D0 GB 0621822 A GB0621822 A GB 0621822A GB 0621822 D0 GB0621822 D0 GB 0621822D0
Authority
GB
United Kingdom
Prior art keywords
hypoglyceamia
nocturnal
predictor
diabetes
individuals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0621822.6A
Other versions
GB2443434A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0621822A priority Critical patent/GB2443434A/en
Publication of GB0621822D0 publication Critical patent/GB0621822D0/en
Publication of GB2443434A publication Critical patent/GB2443434A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
GB0621822A 2006-11-02 2006-11-02 Method for predicting nocturnal hypoglycaemia Withdrawn GB2443434A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0621822A GB2443434A (en) 2006-11-02 2006-11-02 Method for predicting nocturnal hypoglycaemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0621822A GB2443434A (en) 2006-11-02 2006-11-02 Method for predicting nocturnal hypoglycaemia

Publications (2)

Publication Number Publication Date
GB0621822D0 true GB0621822D0 (en) 2006-12-13
GB2443434A GB2443434A (en) 2008-05-07

Family

ID=37547191

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0621822A Withdrawn GB2443434A (en) 2006-11-02 2006-11-02 Method for predicting nocturnal hypoglycaemia

Country Status (1)

Country Link
GB (1) GB2443434A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113951879A (en) * 2021-12-21 2022-01-21 苏州百孝医疗科技有限公司 Blood glucose prediction method and device and system for monitoring blood glucose level

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
EP1680175B1 (en) 2003-11-06 2019-06-05 LifeScan, Inc. Drug delivery pen with event notification means
WO2006072035A1 (en) 2004-12-29 2006-07-06 Lifescan Scotland Limited Method of inputting data into an analyte testing device
US8758245B2 (en) 2007-03-20 2014-06-24 Lifescan, Inc. Systems and methods for pattern recognition in diabetes management
SG193205A1 (en) 2008-08-15 2013-09-30 Lifescan Scotland Ltd Analyte testing method and system
EP2409253B1 (en) * 2009-03-16 2018-12-05 Roche Diabetes Care GmbH Method for automated creation of a user-specific measurement data creation regime for non-continuous blood sugar measurement, data processing device and blood sugar measuring device
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
US10383580B2 (en) 2012-12-31 2019-08-20 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US10010291B2 (en) 2013-03-15 2018-07-03 Abbott Diabetes Care Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
CN113080949B (en) * 2021-03-30 2023-09-22 北京京东拓先科技有限公司 Hypoglycemia early warning method and device and computer storage medium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572542B1 (en) * 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
DE60133653T2 (en) * 2000-08-18 2009-06-04 Animas Technologies Llc APPARATUS FOR PREDICTING HYPOGLYECURE DROPS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113951879A (en) * 2021-12-21 2022-01-21 苏州百孝医疗科技有限公司 Blood glucose prediction method and device and system for monitoring blood glucose level

Also Published As

Publication number Publication date
GB2443434A (en) 2008-05-07

Similar Documents

Publication Publication Date Title
GB0621822D0 (en) Predictor of nocturnal hypoglyceamia for individuals with diabetes
EP2370466B8 (en) Human anti-alpha-synuclein autoantibodies
EP1982167A4 (en) Biosensor
EP2013701A4 (en) Disambiguation of named entities
EP2083074A4 (en) Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase
IL205353A0 (en) Diagnostic biomarkers of diabetes
EP2001362A4 (en) Quantitative optoacoustic tomography with enhanced contrast
HK1159530A1 (en) Immobilised biological entities
EP1985234A4 (en) Lancet
HK1128396A1 (en) Lancet
EP2017608A4 (en) Biosensor
EP2069477A4 (en) Chemorepulsion of cells
TWI320362B (en) Enhanced imaging of features
GB0601695D0 (en) Lancet
EP2122350A4 (en) Detection of analytes
EP2017607A4 (en) Biosensor
GB0622144D0 (en) Biosensor
GB0803275D0 (en) Hinge mechanism
EP2047267A4 (en) Biosensor
EP2050008A4 (en) Personal directory services with presence indication
GB0816384D0 (en) Hinge
GB0621105D0 (en) Hinge
EP2134738A4 (en) Methods for identifying diabetes and obesity therapeutics
GB0612370D0 (en) Uses of (S)-clenbuterol
AP2625A (en) Biosensor

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)